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Abstract
Toxicomania is a worldwide emerging problem threatening young population. Several 
reports highlighted its hazardous cardiovascular effects. Sudden cardiac death second-
ary to cardiac arrhythmias is the most occupying issue. Different forms of cardiac rhythm 
disorders may be induced by illicit drug abuse according to the type of drug and the 
mechanism involved. In this review, we exposed the main ventricular and supraven-
tricular arrhythmia complicating the common recreational drugs, and we explained their 
different mechanisms as well as the particularities of management.
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1. Introduction
Toxicomania is a worldwide health and social problem. In 2015, the World Health 
Organization estimates that 255 millions of people are drug users and more than 10% of 
them have health disorders [1]. In Tunisia, the issue is more complicated as drug abuse 
begins at a very early age, affecting 4.2% of students aged between 15 and 17 years old [2]. 
This finding results in a chronic use and a more accumulation of these substances leading 
to serious health complications, among which cardiovascular ones are the most occupying 
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mainly acute coronary syndromes and rhythm disturbances resulting in more and more 
reported young’s sudden cardiac deaths [3].
Most of the researches have focused on mental health effects and neurotoxicity of illicit drugs. 
Some of them were interested to cardiovascular dangers in general, and they were almost 
cases or series reports. The current review will focus on the topic of cardiac arrhythmias sec-
ondary to drug abuse in which we will explain their different mechanisms and principles of 
management.
2. Cocaine
This “white powder,” extracted from coca leaves, is not only one of the oldest known stimu-
lants but also the most known cardiotoxic illicit drug.
Several cases and series of sudden death, in the hours following cocaine consumption, were 
reported. The main likely cause is cocaine-induced arrhythmia [3].
Four mechanisms are implicated in the genesis of arrhythmia in case of cocaine intoxica-
tion: sodium channel blockade, potassium channel blockade, catecholamine excess, and 
finally myocardial infarction (MI) and myocarditis [4]. Recently, sinus bradycardia has been 
described as a result of chronic cocaine use [5–7] that may be related to a cocaine-induced 
desensitization of beta-adrenergic receptors [6].
The main measure for patients suffering from cocaine-induced arrhythmia is withholding the 
drug and referring to a detoxification center to prevent recurrent events. In addition, specific 
strategies should also be conducted according to the type of arrhythmia.
2.1. Sodium channel blockade
• Wide QRS tachycardia related to sodium channel blockade and reentry ventricular 
tachycardia
First, the blockade of fast inward sodium channels by cocaine is well described as a class IC 
effect according to the Vaughan-Williams classification of antiarrhythmic agents. Modulators 
of the effect of cocaine are increased in heart rate and decreased in pH which increases the 
degree of sodium channel blockade [8].
Electrocardiographic (ECG) manifestations mimic those of other sodium channel blockers, 
drugs and toxins, as tricyclic antidepressants. These manifestations depend on the degree of 
intoxication. In fact, early and minimal toxicity results in the impairment of conduction on the 
right side leading to a rightward axis deviation and QRS duration prolongation, and then, as 
toxicity increases, a right bundle branch block (RBBB) appears in the precordial leads (Figure 1). 
This pattern associated with sinus tachycardia, often shown in case of cocaine intoxication, may 
be confused with a true ventricular tachycardia resulting from a reentry or focal mechanism 
that can also complicate cocaine intoxication as reported in many series [4, 9, 10].
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To manage this wide QRS tachycardia related to sodium channel blockade, general mea-
sures should rapidly be initiated. Oxygenation and ventilation should be optimized, and 
rapid cooling should be initiated when extreme hyperthermia is present. Sedation with a 
benzodiazepine is indicated to control behavior, to lower heart rate which may be sufficient 
to improve conduction and for its antianginal effects in patients with cocaine-associated acute 
coronary syndrome [4, 11].
This electrocardiographic manifestation, occurring in case of acute intoxication and mediated 
by pH decrease, is reversed by hypertonic sodium bicarbonate [8, 12, 13]. In case of persis-
tence of this tachycardia with abnormal QRS prolongation, antiarrhythmic drugs should be 
administrated. Class IA and class IC antiarrhythmic drugs are classically contraindicated as 
they may potentiate QRS enlargement via a synergistic action on sodium channels. In con-
trast, lidocaine (class IB) can compete with cocaine for binding to the sodium channel, and it 
has a rapid offset responsible for the decrease in QRS duration. However, it was suggested 
that lidocaine exacerbated cocaine-associated seizures and arrhythmias as a result of similar 
effects on sodium channels [14]. Beta-blockers are contraindicated in case of cocaine intoxi-
cation as they exacerbate coronary vasospasm resulting in an increased risk of myocardial 
infarction [11]. No data exist concerning the efficacy of amiodarone in clinical cocaine intoxi-
cation [11].
• Brugada-like pattern
Moreover, a classic Brugada pattern has been noted in cocaine users, as seen with class IA 
antiarrhythmic drugs [15, 16]. It is quite likely that these patients express a sodium channel 
mutation described in association with Brugada abnormality and that the sodium channel 
blocking properties of cocaine made the patients’ underlying physiological abnormality more 
evident [4]. Recently, El Mazloum et al. reported four cases of out-of-hospital cardiac arrest 
after acute cocaine intoxication associated with Brugada ECG patterns [17].
Figure 1. ECG performed after a wide QRS tachycardia cardioversion showing a complete right bundle branch block in 
a 38-year-old man with 10 years use of cocaine.
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Cocaine abuse should be stopped. Mostly, ECG reverts toward normal as toxicity resolves 
[13]. Otherwise, sudden cardiac death risk should be evaluated, and implantable cardioverter 
defibrillator should be discussed in coordination with cardiac electrophysiologists.
2.2. Potassium channel blockade
Cocaine is known to block the rectifying potassium channels resulting in QT interval pro-
longation and hyperpolarization leading to early and late afterdepolarizations. If an after-
depolarization of significant magnitude occurs at a time when a critical number of cells can 
conduct an impulse, an ectopic beat can trigger a reentrant rhythm, and monomorphic ven-
tricular tachycardia or torsades de pointes (TdP) occur [18–21].
Management of TdP and QT prolongation resulting from cocaine-associated potassium chan-
nel blockade is similar to those from other causes. In fact, for QT prolongation, electrolytic 
abnormalities, mainly hypokalemia and hypomagnesaemia, should be identified and rap-
idly corrected. Prophylactic magnesium is also suggested in patients with QT interval above 
500 ms [4]. In case of TdP, magnesium, potassium replacement, and even overdrive are the 
main treatments. QT prolonging drugs should be withheld [4, 22].
2.3. Catecholamine excess
The common acute effect of cocaine is to block the presynaptic uptake of dopamine, norepi-
nephrine, and epinephrine, resulting in an augmented level of these neurotransmitters at the 
postsynaptic terminal, producing an exaggerated catecholamine effect [23–25].
This produces sinus tachycardia, a very common finding in these patients, reentrant supra-
ventricular tachycardia [26], and atrial fibrillation, noted in case and series reports [27].
Supportive care is generally sufficient to control sinus tachycardia. Sedation with benzodiazepine, 
oxygen, cooling, and volume resuscitation are the main measures. For reentrant supraventricu-
lar tachycardia, the use of a calcium channel blocker is often required. Finally, atrial fibrillation 
should be classically treated, using short-acting drugs as rhythm is generally controlled when 
toxicity resolves and avoiding β-blockers and class IA and IC antiarrhythmic drugs [4].
2.4. Myocardial infarction and myocarditis
The risk of myocardial infarction is multiplied by 24 within the next hour following cocaine 
consumption [28]. Cocaine-associated myocardial ischemia and infarction is a multifactorial 
process that results from increased demand, vasospasm, enhanced coagulation, impaired 
thrombolysis, and accelerated atherogenesis [29]. A catecholamine excess (trigger) induced 
by cocaine on such a vulnerable myocardium (substrate) may provoke the development of 
ventricular arrhythmias and sudden cardiac death.
In addition to myocardial infarction, scar-related macroreentrant ventricular tachycardia may 
also complicate cocaine-induced acute toxic myocarditis (Figure 2) as demonstrated in several 
case and series reports [30–32].
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When a cocaine-associated acute myocardial infarction is diagnosed, classical antithrombotic 
therapies should be administrated according to current guidelines, and primary PCI should 
be rapidly performed. Moreover, benzodiazepine should be initiated, and β-blockers have to 
be avoided because of the risk of further vasospasm [11, 33].
For scar-related reentry, as well as focal, ventricular tachycardia, management is based on 
classical measures and therapies according to current guidelines [34] with respect of the 
above-cited particularities and contraindications related to cocaine intoxication. In addition, 
implantable cardioverter defibrillator implantation should be deferred until the resolution of 
the acute episode [32, 34].
Besides these therapies, radiofrequency ablation using 3D mapping was described to be 
an effective therapy in 86% of drug refractory ventricular tachycardia related to cocaine 
use [10].
2.5. Sinus bradycardia and early repolarization pattern
Recent reports have demonstrated that chronic cocaine use is a strong predictor of sinus 
bradycardia compared with a matched group of nonusers and resulted in three- to seven-
fold increased risk of sinus bradycardia [5–7]. Despite the presence of sinus bradycardia, all 
patients were able to augment their sinus rate with activity [6].
Sharma et al. have showed also that current cocaine dependence corresponds to an increased 
odd of demonstrating early repolarization by a factor of 4.92 [5].
Common physiological manifestations of cocaine are related to its adrenergic effects. However, 
with chronic exposure to cocaine, Franklin et al. have postulated that the mechanism of sinus 
bradycardia may be related to a cocaine-induced desensitization of beta-adrenergic receptors.
A blockage of the fast sodium current reduces sinus node automaticity, and results in brady-
cardia have also been evocated [6].
Figure 2. Cardiac magnetic resonance imaging revealing a late gadolinium enhancement (LGE) of the subepicardial 
layers of the septal and lateral walls of the left ventricle in a cocaine abuse man admitted for a ventricular tachycardia 
management.
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3. Cannabis
Because of its accessibility and legality of use in many countries, cannabis, also known as 
“marijuana” or “hashish,” is the most consumed drug in Tunisia and all over the world [1, 2]. 
Cardiovascular complications of cannabis use rose from 1.1 to 3.6% between 2006 and 2010 
among 9936 abusers according to the French Addictovigilance Network, most of them pre-
senting with an acute coronary syndrome, while two patients had cardiac arrhythmia [35]. 
Due to its widespread use and of possible harmful cardiovascular impact reported in many 
case and series reports, cardiologists should be sensitized to detect its potential dangerous 
effects and be able to prevent and manage them properly.
Cannabis is rapidly absorbed through the lungs and less so with ingestion. The effects of the 
drug can last up to 6 hours with the onset of arrhythmias beginning anywhere from within a 
few minutes to a few hours of smoking and with a peak at 30 minutes [36].
Delta-9-tétrahydrocannabinol (Δ-9-THC), the active agent of cannabis, exercises its action via 
the cannabinoid system with its two receptors CB1 and CB2. This system induces modifica-
tions of the regulation of the autonomic nervous system leading to cardiovascular conse-
quences and of central nervous system resulting in psychoneurological effects [37, 38].
Most published reports have focused on incidents of acute coronary syndromes and acute cere-
brovascular and peripheral vascular events. However, an increasing number of case reports indi-
cate an association between cannabis use and cardiac arrhythmias mainly atrial fibrillation (AF) 
and ventricular arrhythmias (Figure 3) [39]. Management and reversibility of these arrhythmias 
are similar to those induced by cocaine abuse and will not be re-explained in this chapter.
In fact, cannabis has a biphasic effect on the autonomic nervous system.
3.1. Increase in sympathetic activity
At low to moderate doses, THC leads to an increase in sympathetic activity causing sinus tachycar-
dia with a rise of 20–100% of the heart rate, premature ventricular beats associated with increased 
cardiac output and hypertension [36]. The concept of sympathetic activation is supported by 
studies demonstrating an increased urinary excretion of epinephrine after THC use [40].
Atrial fibrillation is another complication of acute cannabis intoxication. A recent study 
focused on causes of atrial fibrillation in young people ≤45 years old. Among 88 patients, 22 of 
them, the atrial fibrillation was directly related to alcohol (86.4%), cannabis (13.6%), or cocaine 
abuse (4.5%) [41]. In a systematic review published in 2008, six reported cases were analyzed. 
In all instances, AF was of recent onset occurring shortly after marijuana smoking in young 
subjects. No patient had a structural heart disease, and only one had a precipitating factor 
(hypertension); all patients had a favorable outcome with no recurrence after cessation of 
marijuana smoking [42]. Of note, adrenergic stimulation and disturbances in atrial coronary 
or microvascular flow associated with marijuana smoking may facilitate AF development and 
perpetuation possibly because of increased pulmonary vein ectopy, enhanced atrial electrical 
remodeling, and increased dispersion of refractoriness [42]. It should also be stressed that 
although this adverse event seems to be quite “benign” in young healthy subjects, it is appar-
ently more “malignant” in older patients having other risk factors for thromboembolism. 
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Finally, we should note that the burden of this problem is possibly underestimated given 
euphoric and neuropsychological effects of marijuana that may cover palpitations, possible 
occurrence of unnoticed short episodes of AF and because of social and legal reasons leading 
most users of illicit drugs to avoid seeking medical attention [43]. AF onset in young patients 
without structural heart disease should pay attention to an eventual illicit drug abuse. Its 
identification is very important because drug cessation will protect against AF recurrences.
3.2. Increase in parasympathetic activity
In contrast, at higher doses, parasympathetic activity is increased causing bradycardia and 
hypotension [36].
Bradyarrhythmias such as sinus bradycardia and higher-degree atrioventricular block have 
been reported. And, these conduction disturbances were reversible 72 hours after drug ces-
sation [44].
The most described parasympathetic complication of cannabis abuse is vasovagal and pos-
tural syncope leading in some cases to sinus asystole. In a  randomized controlled trial where 
29 volunteers had participated, the effects of THC infusion and marijuana smoking when 
reclining and standing were studied. Both THC and marijuana-induced postural dizziness, 
with 28% reporting severe symptoms immediately after drug administration. The severe diz-
ziness group showed the most marked postural drop in cerebral blood velocity and blood 
pressure and showed a drop in pulse rate after an initial increase during standing [45, 46].
3.3. Acute coronary syndrome
The risk of myocardial infarction (MI) is 4.8-fold increased in the first hour following mari-
juana use [47]. Urgent coronary angiography practiced in these victims of cannabis-induced 
MI may show angiographically normal coronary arteries supposing a spastic mechanism or 
an increased myocardial oxygen demand due to increased sympathetic activity. Coronary 
Figure 3. ECG showing a ventricular tachycardia at 170 beats/min with left bundle branch block pattern and left QRS 
axis in a 39-year-old man with a history of chronic cannabis use.
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arteries may also be very thrombotic with or without atherosclerotic plaque rupture. Finally, 
a no-flow or slow-flow with normal appearing epicardial vessels was reported as well [48]. 
Ventricular tachycardia and sudden cardiac death were reported as a complication of canna-
bis-induced MI [49].
3.4. Sodium channel blockade
A Brugada-like effect was reported to be associated to cannabis intoxication as described with 
cocaine abuse [50–52]. This ECG pattern is believed to be related to a partial sodium channel 
antagonist activity. The ST segment normalizes once the acute intoxication is resolved.
4. Amphetamines and derivatives: ecstasy and methamphetamines
These synthetic drugs are used for their psychostimulant effects. They had been first used by 
German army during the Second World War for these sought effects. Later, their cardiovas-
cular dangers were revealed.
The main mechanism of action is an indirect sympathomimetic effect by releasing norepi-
nephrine, dopamine, and serotonin from central and autonomic nervous system terminals, 
leading, as in cocaine intoxication, to an increase in the central and peripheral catecholamine 
concentrations [53].
High catecholamine levels are known to be cardiotoxic, causing vasospasm, tachycardia, and 
hypertension, leading to increased myocardial oxygen demand and myocyte necrosis and 
fibrosis [54].
The association of these stimulants and sudden cardiac death is well established. A recent 
histopathological study showed that among 100 methamphetamine poisoning-related deaths, 
68% had cardiac lesions [55]. In this context, death can result either from lethal aortic dis-
section or from ventricular arrhythmia. This latter may complicate either type 1 and type 2 
myocardial infarctions or methamphetamine-induced cardiomyopathy and is triggered by 
catecholamine excess [56]. Furthermore, according to an interesting recent study, among 230 
amphetamine abuser patients, 43% presented with sinus tachycardia and 3.5% presented 
with cardiac arrhythmias: ventricular tachycardia, premature atrial beats, paroxysmal supra-
ventricular tachycardia, and premature ventricular beats [57].
5. Heroine
Morphine and its semisynthetic analogue heroin are the most commonly used recreational 
narcotic drugs. Narcotic agents act centrally on the vasomotor center to increase parasympa-
thetic and reduce sympathetic activity [48, 53]. These autonomic changes, combined with his-
tamine release from mast cell degranulation, can result in bradycardia and hypotension [53]. 
Sinus bradycardia, benign atrioventricular block, and resulting atrial or ventricular automatic 
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ectopy and tachycardia were all reported. ECGs of 511 opioid addicts were analyzed. The 
main anomalies detected were sinus bradycardia, type-1 atrioventricular block, wandering 
atrial pacemaker, supraventricular and ventricular ectopic beats, and QT prolongation [58].
Methadone is another synthetic opioid used for the treatment of opioid addiction and for its 
analgesic effect. Methadone is responsible for QT prolongation and occurrence of torsade de 
pointes (TdP) especially when QT interval exceeds 500 ms. TdP should always be suspected 
in patients receiving methadone and presenting with syncope [59, 60]. Correction of predis-
posing factors as hypokalemia and hypomagnesemia is recommended, in case of prolonged 
QT and TdP. Magnesium perfusion is proposed, even in case of normal serum magnesium 
concentration. Alternative drugs can be used when corrected QT exceeds 500 ms [59].
6. Lysergic acid diethylamide and psilocybin
Lysergic acid diethylamide (LSD) and psilocybin “magic mushrooms” are commonly used 
hallucinogenic agents in developed countries. LSD is about 100 times more potent than psi-
locybin. Their mechanisms of action are complex and include agonist, partial agonist, and 
antagonist effects at various serotonin, dopaminergic, and adrenergic receptors. The adren-
ergic effects are usually mild and do not produce the profound sympathetic storms that can 
occur after taking cocaine, amphetamine, or ecstasy. Besides common sinus tachycardia, car-
diovascular complications are rarely serious, although occasional instances of supraventricu-
lar tachyarrhythmias and myocardial infarction have been reported [61, 62].
7. Inhalent abuse
Inhalant abuse is the intentional inhalation of chemical vapors by sniffing, snorting, bag-
ging, or huffing the substance to attain a euphoric effect. Spray paints, shoe polish, dust-off 
spray, glue, and lighter fluids are some products commonly abused by people. Glue sniff-
ing has become a widespread form of inhalant abuse, usually among in adolescents and 
young adults.
Studies have indicated that about 20% of children in middle and high schools have experi-
mented with inhalant substances [63]. These products are cheap, easily accessible at home, 
school, and workplace, and they are legal for all age groups (e.g., glue). Many common house-
hold products containing halogenated hydrocarbon like 1,1-difluoroethane (DFE) (known as 
Freon 152A used in refrigeration, dust-off spray, and airbrush painting) and toluene (used in 
glues) are abused by inhalation for euphoric effects [64].
Halogenated hydrocarbon abuse can cause a fatal malignant arrhythmia, termed “sudden 
sniffing death.” Cardiotoxic effects have been described in human and in animal models [64].
Avella et al. [65] have demonstrated different levels in DFE tissues in the brain and heart, 
but the DFE level in the heart remained higher than the brain tissue after approximately 
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60-second post-DFE withdrawal. This may further result in abuser inhaling more DFE to 
sustain euphoric effect because central nervous system effects are reduced and thus lead to 
accumulation in the heart.
Recently, Joshi et al. [66] have showed that after multiple DFE doses in rats, severe arrhyth-
mias such as ventricular fibrillation and ventricular tachycardia can be triggered. Exposure 
causes significant higher amount of epinephrine release than the control group [66] and an 
increased sensitivity of the myocardium to epinephrine [64, 67]. Furthermore, electrolyte 
imbalance, cardiac biomarkers, and oxidative stress markers were significantly affected and 
can cause damage to cardiomyocytes [66].
Alper et al. have demonstrated increase in QT duration, QT, and QTc dispersion in toluene 
users [68]. Toluene can cause inhibition of cardiac sodium currents like class I antiarrhythmics 
which can cause prolonged QT interval and have proarrhythmic effects [69].
Although the electrical function of the heart can be altered with acute exposure to hydrocar-
bons, prolonged use can cause structural damage that may also impede normal function [64].
Samples of cardiac muscle taken from inhalant abusers have shown interstitial edema, intra-
myocardial hemorrhages, contraction band necrosis, [70] edema, swollen and ruptured myo-
fibrils, [71] and myocarditis and interstitial fibrosis [72].
In addition to arrhythmias, halogenated hydrocarbons have negative inotropic, dromotropic, 
and chronotropic effects on cardiac tissue [73]. Cases of atrioventricular conduction abnor-
mality have been described in toluene intoxication [74].
8. Conclusion
Cardiac arrhythmia presents a potential dangerous complication leading to sudden car-
diac death threatening young population. The most important mechanisms implicated in 
the genesis of arrhythmia in case of illicit drug intoxication are sodium channel block-
ade, potassium channel blockade, catecholamine excess, and finally myocardial infarction 
and myocarditis. Atrial fibrillation onset in young patients without structural heart dis-
ease should pay attention to an eventual illicit drug abuse. Its identification is very impor-
tant because drug cessation will protect against atrial fibrillation recurrences. Table 1 
resumes physiopathological effects and main induced arrhythmias of commonly abused 
illicit drugs. Management should consist, first, on withholding drug intoxication with the 
collaboration of a detoxification center to prevent recurrent events, and, second, on com-
mon recommended measures as for the treatment of nondrug abuse arrhythmias with 
respect of some particularities and contraindications as in the case of cocaine intoxication. 
Thus, acute management of wide QRS tachycardia related to sodium channel blockade 
secondary to drug abuse, include oxygenation, sedation with benzodiazepine, and hyper-
tonic sodium bicarbonate perfusion. Class IA and class IC antiarrhythmic drugs and beta-
blockers are classically contraindicated. Electrical cardioversion is indicated in case of all 
hemodynamically unstable arrhythmias.
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Illicit drug Physiopathological effects Induced cardiac arrhythmias
Cocaine Sodium channel blockade QRS enlargement with right bundle 
branch block
Brugada-like syndrome
Potassium channel blockade QT prolongation
Torsade de pointes
Catecholamine excess Sinus tachycardia
Supraventricular tachycardia
Myocardial infarction/myocarditis Ventricular tachycardia/fibrillation
Cocaine-induced desensitization of beta-
adrenergic receptors
Sinus bradycardia
Cannabis Increase in sympathetic activity Sinus tachycardia
Atrial fibrillation
Premature ventricular beats
Increase in parasympathetic activity Sinus bradycardia
Atrioventricular block
Vasovagal and postural syncope
Sinus asystole
Myocardial infarction Ventricular tachycardia/fibrillation
Sodium channel blockade Brugada-like syndrome
Methamphetamine and ecstasy Catecholamine excess Sinus tachycardia
Supraventricular tachycardia
Myocardial infarction Ventricular tachycardia/fibrillation
Heroine and morphine 
methadone
Increase parasympathetic and reduce 
sympathetic activity
Sinus bradycardia
Atrial or ventricular ectopy
Potassium channel blockade QT prolongation
Torsade de pointes
LSD and psilocybin Mild catecholamine excess Sinus tachycardia
Table 1. Physiopathological effects and main induced arrhythmias of commonly abused illicit drugs.
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